LAVA Therapeutics NV (FRA:4PKB)
€ 1.61 -0.06 (-3.59%) Market Cap: 43.42 Mil Enterprise Value: -32.23 Mil PE Ratio: 0 PB Ratio: 1.13 GF Score: 49/100

LAVA Therapeutics NV at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 12, 2022 / 11:00AM GMT
Arthur He
H.C. Wainwright & Co. - Analyst

Greetings, everyone. And thank you for joining the H.C. Wainwright 24th Annual Global Investment hybrid conference. My name is Arthur He and I'm a biotech equity research analyst at H.C. Wainwright. While we are hybrid this year, we're confident we're going to be able to provide value to you with over 550 companies presenting at this conference.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total of 26 publishing senior analysts over 643 companies covered across all sectors. Please visit hcwco.com for more information.

The in-person venue for the event is the large New York Palace Hotel in New York City. Virtual participation will be staged simultaneously with over 550 company presentations scheduled as live feed and available on demand. Please join us for one-on-one meetings, corporate presentations and panels that will be available live and streaming on September 12 to 14.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot